Your browser doesn't support javascript.
loading
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia.
Murray, Heather C; Enjeti, Anoop K; Kahl, Richard G S; Flanagan, Hayley M; Sillar, Jonathan; Skerrett-Byrne, David A; Al Mazi, Juhura G; Au, Gough G; de Bock, Charles E; Evans, Kathryn; Smith, Nathan D; Anderson, Amanda; Nixon, Brett; Lock, Richard B; Larsen, Martin R; Verrills, Nicole M; Dun, Matthew D.
Afiliação
  • Murray HC; Cancer Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Enjeti AK; Calvary Mater Newcastle Hospital, Waratah, NSW, 2298, Australia.
  • Kahl RGS; NSW Health Pathology, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, Australia.
  • Flanagan HM; School of Medicine and Public Health Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Sillar J; Cancer Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Skerrett-Byrne DA; Cancer Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Al Mazi JG; Cancer Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Au GG; Calvary Mater Newcastle Hospital, Waratah, NSW, 2298, Australia.
  • de Bock CE; Viruses, Infections/Immunity, Vaccines and Asthma Program, Hunter Medical Research Institute, and School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Evans K; Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Smith ND; Cancer Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Anderson A; Viruses, Infections/Immunity, Vaccines and Asthma Program, Hunter Medical Research Institute, and School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Nixon B; Children's Cancer Institute Australia, School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.
  • Lock RB; Children's Cancer Institute Australia, School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.
  • Larsen MR; Analytical and Biomolecular Research Facility, Advanced Mass Spectrometry Unit, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Verrills NM; Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Dun MD; Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, 2308, Australia.
Leukemia ; 35(6): 1782-1787, 2021 06.
Article em En | MEDLINE | ID: mdl-33067575

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Fosfoproteínas / Leucemia Mieloide Aguda / Morfolinas / Cromonas / Proteoma / Sinergismo Farmacológico / Benzotiazóis / Proteína Quinase Ativada por DNA / Tirosina Quinase 3 Semelhante a fms Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Fosfoproteínas / Leucemia Mieloide Aguda / Morfolinas / Cromonas / Proteoma / Sinergismo Farmacológico / Benzotiazóis / Proteína Quinase Ativada por DNA / Tirosina Quinase 3 Semelhante a fms Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália